Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PG9
Description:
PG9 is a human broadly neutralizing antibody targeting the HIV-1 envelope V2-apex region; the name also identifies an analgesic compound.
Primary topic:
HIV Research and Treatment (78%)
Related topics:
HIV Research and Treatment (78%),
Carbohydrate Chemistry and Synthesis (7%)
OpenAlex ID:
keywords/pg9
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
2011
·
Mattia Bonsignori
, Kwan-Ki Hwang
, et al.
·
Journal of Virology
·
457
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
2010
·
Laura M. Walker
, Melissa D. Simek
, et al.
·
PLoS Pathogens
·
398
PDF
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
2013
·
Marie Pancera
, Syed Shahzad-ul-Hussan
, et al.
·
Nature Structural & Molecular Biology
·
283
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
2013
·
Jean-Philippe Julien
, Jeong Hyun Lee
, et al.
·
Proceedings of the National Academy of Sciences
·
264
PDF
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
2014
·
Amarendra Pegu
, Zhi-yong Yang
, et al.
·
Science Translational Medicine
·
263
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
2010
·
Katie J. Doores
, Dennis R. Burton
·
Journal of Virology
·
257
Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1
2010
·
Marie Pancera
, Jason S. McLellan
, et al.
·
Journal of Virology
·
253
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1
2010
·
Robert Pejchal
, Laura M. Walker
, et al.
·
Proceedings of the National Academy of Sciences
·
226
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
2015
·
Raiees Andrabi
, James E. Voss
, et al.
·
Immunity
·
202
PDF
Genetic and physical mapping ofLrk10-like receptor kinase sequences in hexaploid oat (Avena sativaL.)
2002
·
Davis W Cheng
, Ken C Armstrong
, et al.
·
Genome
·
182
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
2014
·
Anila Yasmeen
, Rajesh Ringe
, et al.
·
Retrovirology
·
162
PDF
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site
2015
·
Ema T. Crooks
, Tommy Tong
, et al.
·
PLoS Pathogens
·
150
PDF
Human Peripheral Blood Antibodies with Long HCDR3s Are Established Primarily at Original Recombination Using a Limited Subset of Germline Genes
2012
·
Bryan S. Briney
, Jordan R. Willis
, et al.
·
PLoS ONE
·
143
PDF
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
2013
·
Wenbo Wang
, Jianhui Nie
, et al.
·
Retrovirology
·
133
PDF
Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses
2011
·
Hugo Mouquet
, Florian Klein
, et al.
·
PLoS ONE
·
122
PDF
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
2013
·
Mohammed N Amin
, Jason S McLellan
, et al.
·
Nature Chemical Biology
·
115
Efficient Convergent Synthesis of Bi-, Tri-, and Tetra-antennary Complex Type N-Glycans and Their HIV-1 Antigenicity
2013
·
Sachin S. Shivatare
, Shih-Huang Chang
, et al.
·
Journal of the American Chemical Society
·
104
Reprogramming the antigen specificity of B cells using genome-editing technologies
2019
·
James E. Voss
, Alicia Gonzalez-Martin
, et al.
·
eLife
·
99
A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
2012
·
Nicole A. Doria-Rose
, Ivelin Georgiev
, et al.
·
Journal of Virology
·
86
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D
2013
·
Andrew T. McGuire
, Jolene A. Glenn
, et al.
·
Journal of Virology
·
83
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors
2013
·
S. Munir Alam
, S. Moses Dennison
, et al.
·
Proceedings of the National Academy of Sciences
·
81
PDF
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
2022
·
Jordan R. Willis
, Zachary T. Berndsen
, et al.
·
Immunity
·
79
PDF
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
2012
·
Joshua Baalwa
, Shuyi Wang
, et al.
·
Virology
·
77
Identification of an HIV-1 Clade A Envelope That Exhibits Broad Antigenicity and Neutralization Sensitivity and Elicits Antibodies Targeting Three Distinct Epitopes
2013
·
Simon Hoffenberg
, Rebecca Powell
, et al.
·
Journal of Virology
·
74
PDF
The human anti‐HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down‐regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant‐based expression platforms
2014
·
Melanie Niemer
, Ulrich Mehofer
, et al.
·
Biotechnology Journal
·
73
PDF
Show more works
View as search
Works count:
125
Citation count:
5,186
Year
Topic
Type